Elevating EGFR-MAPK program by a nonconventional Cdc42 enhances intestinal epithelial survival and regeneration. Academic Article uri icon

Overview

abstract

  • The regulatory mechanisms enabling the intestinal epithelium to maintain a high degree of regenerative capacity during mucosal injury remain unclear. Ex vivo survival and clonogenicity of intestinal stem cells (ISCs) strictly required growth response mediated by cell division control 42 (Cdc42) and Cdc42-deficient enteroids to undergo rapid apoptosis. Mechanistically, Cdc42 engaging with EGFR was required for EGF-stimulated, receptor-mediated endocytosis and sufficient to promote MAPK signaling. Proteomics and kinase analysis revealed that a physiologically, but nonconventionally, spliced Cdc42 variant 2 (V2) exhibited stronger MAPK-activating capability. Human CDC42-V2 is transcriptionally elevated in some colon tumor tissues. Accordingly, mice engineered to overexpress Cdc42-V2 in intestinal epithelium showed elevated MAPK signaling, enhanced regeneration, and reduced mucosal damage in response to irradiation. Overproducing Cdc42-V2 specifically in mouse ISCs enhanced intestinal regeneration following injury. Thus, the intrinsic Cdc42-MAPK program is required for intestinal epithelial regeneration, and elevating this signaling cascade is capable of initiating protection from genotoxic injury.

authors

  • Zhang, Xiao
  • Bandyopadhyay, Sheila
  • Araujo, Leandro Pires
  • Tong, Kevin
  • Flores, Juan
  • Laubitz, Daniel
  • Zhao, Yanlin
  • Yap, George
  • Wang, Jingren
  • Zou, Qingze
  • Ferraris, Ronaldo
  • Zhang, Lanjing
  • Hu, Wenwei
  • Bonder, Edward M
  • Kiela, Pawel R
  • Coffey, Robert
  • Verzi, Michael P
  • Ivanov, Ivaylo I
  • Gao, Nan

publication date

  • August 20, 2020

Research

keywords

  • ErbB Receptors
  • Intestinal Mucosa
  • Regeneration
  • cdc42 GTP-Binding Protein

Identity

PubMed Central ID

  • PMC7455142

Scopus Document Identifier

  • 85089768554

Digital Object Identifier (DOI)

  • 10.1172/jci.insight.135923

PubMed ID

  • 32686657

Additional Document Info

volume

  • 5

issue

  • 16